0 followers
Promontory Therapeutics Inc. is a clinical stage pharmaceutical company developing small molecule immunotherapies. The company's lead candidate, PT-112, is a novel chemical entity under clinical development that exhibits a unique combination of properties, including immunogenic cell death as well as... Read more
Matthew Price
Charlie Health
5 followers
Tessera Therapeutics
2 followers
Vaxcyte
2 followers
Tarsus Pharmaceuticals
1 follower
Artiva Biotherapeutics
1 follower
Johnson & Johnson
420 followers
Thermo Fisher Scientific
158 followers
Abbott
278 followers
CRISPR Therapeutics
9 followers
Adverum Biotech
8 followers
Legend Biotech
5 followers
Explore companies